Abraham Ceesay - Insider Trading & Ownership

Location
C/O Scpharmaceuticals, Inc., 2400 District Avenue Suite 310, Burlington, MA
Summary
The estimated net worth of Abraham Ceesay is at least $20.4M dollars as of September 19, 2025. Abraham Ceesay is the Chief Executive Officer, Director of Rapport Therapeutics, Inc. and owns shares of Rapport Therapeutics, Inc. (RAPP) stock worth about $18.2M. Abraham Ceesay is the President of Cerevel Therapeutics Holdings, Inc. and owns shares of Cerevel Therapeutics Holdings, Inc. stock worth about $1.23M. Abraham Ceesay is the Director of Pacira BioSciences, Inc. and owns shares of Pacira BioSciences, Inc. (PCRX) stock worth about $570K. Abraham Ceesay is the Director of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. and owns shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) stock worth about $409K.
Signature
/s/ Troy Ignelzi, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Abraham Ceesay

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RAPP Rapport Therapeutics, Inc. Chief Executive Officer, Director $18.2M -$2.01M -9.95% Sep 17, 2025
CERE Cerevel Therapeutics Holdings, Inc. President $1.23M Feb 6, 2023
PCRX Pacira BioSciences, Inc. Director $570K -$64K -10.1% Sep 4, 2025
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Director $409K Jun 2, 2025

Insider Transactions Reported by Abraham Ceesay:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.